New York, which was once the epicenter of the country’s epidemic, has gradually reopened regions based on when they meet certain epidemiological requirements that measure the severity of the local epidemic. New York City, the hardest hit part of the state, entered phase 1 of reopening on Monday.
This first phase of reopening will send up to 400,000 New Yorkers to work, previously said Mayor Bill de Blasio.
“We know that reopening other states has serious problems,” Cuomo said on Tuesday. “Twelve states that have reopened are now seeing spikes. It’s a very real possibility. The countries of the world that have reopened are seeing spikes. ”
Cuomo highlighted other states, particularly Florida, that have experienced a resurgence of the virus since it reopened. Florida reported approximately 1,400 new confirmed cases of coronavirus on June 6, its highest in a day since the state health department began tracking the epidemic in mid-March. New daily cases in the state have remained around 1,000 since June 2, according to the state surveillance dashboard.
Despite increasing cases, Governor Ron DeSantis announced last week that most of the state could enter phase two of the reopening, which eases restrictions on stores and allows bars and theaters to reopen . The virus has infected more than 66,000 people in Florida and killed at least 2,765 people, according to data compiled by Johns Hopkins University.
“Just because you reopen doesn’t mean you have a spike, but if you’re not smart, you can have a spike,” Cuomo said. “We are not well. We have made great progress, but we have to stay smart and we have to stay disciplined. ”
Other states that were among the first and most ambitious to reopen have also reported spikes in recent days. Texas, which began reopening on May 8 and expanded its reopening on May 18, announced a second consecutive day of record hospitalizations at Covid-19 on Tuesday. There are currently 2,056 Covid-19 patients confirmed in Texas hospitals, according to the Texas Department of Health and Human Services. This figure has increased in recent days.
Hospitalization figures better reflect the reopening performance of a state, as it is more difficult to bias than the number of confirmed cases, which varies depending on the number of tests performed.
New cases are also appearing in Arizona, which started reopening in mid-May. New daily cases in the state exceeded 1,000 for the first time on June 1, rising to 1,168 the following day, according to the Arizona Department of Health Services. Since then, the data is incomplete, according to the state. These peaks become of particular concern if the influx of patients begins to stretch public health systems.
The Republic of Arizona reported on Monday that state health director sent a letter on June 6 to hospitals asking them to “fully activate” their emergency plans to ensure hospitals continue to have capacity sufficient. Arizona’s largest healthcare system, Banner Health, told CNBC on Monday that its number of Covid-19 ventilated patients has quadrupled since May 15.
“We have seen a steady increase in COVID-19 cases in Arizona in the past two weeks,” said Dr. Marjorie Bessel, clinical director of Banner Health, in a statement. “This trend is of concern to us, and is also correlated with an increase in the cases we see in our hospital intensive care units. ”
Nationally, confirmed cases have increased since Memorial Day weekend. Although cases are not increasing nationally, they appear to have plateaued at more than 20,000 new confirmed cases each day, according to Hopkins data.
Health officials expected cases to increase when restrictions were relaxed, former Food and Drug Administration commissioner CNBC told CNBC on Tuesday, adding that parts of the country, including Arizona and Texas, look “pretty hot” in terms of spread.
“Make no mistake, we will tolerate a lot of spread of Covid-19 before summer and fall,” he said on CNBC’s “Squawk Box”. “And we’re not going to close again. ”
Disclosure: Scott Gottlieb is a CNBC contributor and is a member of the boards of directors of Pfizer and the biotechnology company Illumina.